1. Camacho Leal, Maria del Pilar, Sciortino, Marianna, Tornillo, Giusy, Defilippi, Paola, Cabodi, Sara. 2015. p130Cas/BCAR1 scaffold protein in tissue homeostasis and pathogenesis. In Gene, 562, 1-7. doi:10.1016/j.gene.2015.02.027. https://pubmed.ncbi.nlm.nih.gov/25727852/
2. Mahmoud, Marwa, Evans, Ian, Wisniewski, Laura, Scambler, Peter, Zachary, Ian. . Bcar1/p130Cas is essential for ventricular development and neural crest cell remodelling of the cardiac outflow tract. In Cardiovascular research, 118, 1993-2005. doi:10.1093/cvr/cvab242. https://pubmed.ncbi.nlm.nih.gov/34270692/
3. Mao, Chun-Guo, Jiang, Sha-Sha, Shen, Cheng, Tan, Qun-You, Deng, Bo. 2020. BCAR1 promotes proliferation and cell growth in lung adenocarcinoma via upregulation of POLR2A. In Thoracic cancer, 11, 3326-3336. doi:10.1111/1759-7714.13676. https://pubmed.ncbi.nlm.nih.gov/33001583/
4. Mao, Chun-Guo, Jiang, Sha-Sha, Wang, Xiao-Yang, Huang, Yi, Deng, Bo. 2021. BCAR1 plays critical roles in the formation and immunoevasion of invasive circulating tumor cells in lung adenocarcinoma. In International journal of biological sciences, 17, 2461-2475. doi:10.7150/ijbs.61790. https://pubmed.ncbi.nlm.nih.gov/34326687/
5. Kazakova, Elena V, Chen, Meijun, Jamaspishvili, Esma, Sun, Lulu, Qiao, Hong. 2018. Association between RBMS1 gene rs7593730 and BCAR1 gene rs7202877 and Type 2 diabetes mellitus in the Chinese Han population. In Acta biochimica Polonica, 65, 377-382. doi:10.18388/abp.2017_1451. https://pubmed.ncbi.nlm.nih.gov/30188962/
6. Jiang, Shasha, Mao, Chunguo, Jiang, Bin, Tan, Qunyou, Deng, Bo. . High Expression of BCAR1 by Circulating Tumor Cells and Tumor Tissues Is Predictive of a Poor Prognosis of Early-Stage Lung Adenocarcinoma Potentially Due to Regulation of Epithelial-Mesenchymal Transition. In Technology in cancer research & treatment, 19, 1533033820983086. doi:10.1177/1533033820983086. https://pubmed.ncbi.nlm.nih.gov/33334252/
7. Fromont, Gaëlle, Vallancien, Guy, Validire, Pierre, Levillain, Pierre, Cussenot, Olivier. . BCAR1 expression in prostate cancer: association with 16q23 LOH status, tumor progression and EGFR/KAI1 staining. In The Prostate, 67, 268-73. doi:. https://pubmed.ncbi.nlm.nih.gov/17192874/